The Need to Reform Current Drug Registration Processes to Improve Access to Essential Medicines in Developing Countries
Authors:
- 1 July 2008
- journal article
- Published by Springer Nature in Pharmaceutical Medicine
- Vol. 22 (4) , 207-213
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Future of HIV Prevention: Prospects for an Effective Anti-HIV MicrobicideInfectious Disease Clinics of North America, 2007
- Editorial: Drug development for neglected diseases: a public health challengeTropical Medicine & International Health, 2006
- Priority setting and the ‘neglected’ tropical diseasesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Registration problems for antiretrovirals in AfricaThe Lancet, 2006
- Harmonization, Regulation, and Trade: Interactions in the Pharmaceutical FieldInternational Journal of Health Services, 2004
- Regulatory Challenges in Microbicide DevelopmentScience, 2004
- A Critique to the European Regulatory SystemJournal of Ambulatory Care Management, 2004
- Drug development for neglected diseases: a deficient market and a public-health policy failureThe Lancet, 2002
- Drugs for neglected diseases: a failure of the market and a public health failure?Tropical Medicine & International Health, 2001
- Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gelEuropean Journal of Clinical Pharmacology, 1992